ARRIVENT BIOPHARMA INC

Ticker: AVBP CUSIP: 04272N102 Class: Common Stock

MARSHALL WACE, LLP's Holding History (CIK: 0001318757)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 98,984 Value ($000) $1,992 Avg Close $20.82 Range $17.00 - $25.82

Q3 2025

Shares 180,223 Value ($000) $3,325 Avg Close $19.65 Range $16.10 - $23.38

Q1 2025

Shares 35,851 Value ($000) $663 Avg Close $24.47 Range $17.84 - $29.71

Q3 2024

Shares 85,250 Value ($000) $2,003 Avg Close $22.70 Range $17.21 - $30.99

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	98,984	$1,992	$20.82	$17.00 - $25.82
Q3 2025	180,223	$3,325	$19.65	$16.10 - $23.38
Q1 2025	35,851	$663	$24.47	$17.84 - $29.71
Q3 2024	85,250	$2,003	$22.70	$17.21 - $30.99